Medicinsk Lustgas Air Liquide (Nitrous Oxide)

Nitrous oxide works by antagonising NMDA receptors, which dampens excitatory neuronal signalling, and by enhancing endogenous opioid pathways that lower pain perception. It also modulates GABAergic activity, contributing to its sedative effect, and influences catecholamine release, supporting its overall anesthetic profile.

The dose of nitrous oxide is individually determined by the prescribing clinician based on the patient’s age, weight, procedure type and required depth of analgesia or sedation. Administration is titrated to effect using calibrated delivery systems, and specific concentration ranges are set by the treating professional.

The pregnancy category for nitrous oxide is listed as unknown, and limited data exist on its safety during lactation. Caution is advised, and the drug should only be used when the potential benefit justifies any possible risk to the fetus or infant. Consultation with an obstetric specialist is recommended.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Nitrous oxide has a rapid onset and quick recovery profile compared with agents such as sevoflurane or desflurane, which may have longer elimination times. It provides modest analgesia and sedation, whereas other inhalational anesthetics often deliver deeper levels of anesthesia. Nitrous oxide is also less potent, requiring higher concentrations, but it offers the advantage of minimal cardiovascular depression when used with adequate oxygen.

Store the gas cylinders at ambient temperature, preferably below 25 °C, in a well‑ventilated, dry area away from direct sunlight and heat sources. Keep cylinders upright, secured to prevent falling, and protect the valve from damage. Follow local regulations for medical gas storage and ensure that only trained personnel handle the product.

The gas is delivered via a calibrated inhalation system, such as a demand‑valve or a face mask, mixed with oxygen to maintain a minimum of 30 % oxygen concentration. The clinician titrates the nitrous oxide concentration to achieve the desired analgesic or sedative effect, continuously monitoring the patient’s vital signs throughout the procedure.

Serious risks include hypoxia if the gas is administered without sufficient oxygen, respiratory depression in susceptible individuals, and potential vitamin B12 deficiency with prolonged exposure, which can lead to neuropathy. Rarely, severe neurotoxicity or cardiovascular instability may occur, especially when combined with other depressant agents.

Patients with severe chronic obstructive pulmonary disease, untreated pneumothorax, increased intracranial pressure, or known hypersensitivity to nitrous oxide should avoid its use. It is also contraindicated in individuals where adequate oxygen supplementation cannot be guaranteed, and in patients receiving certain chemotherapy agents that may interact adversely.